Principals

David de Ferranti, President (and founder) of Results for Development, has over thirty years of experience in leadership and senior management positions in the public and private sector, chiefly in the fields of international development and, earlier, U.S. public policy.

Robert Hecht is a Principal and Managing Director at R4D, with extensive background in health and development policy. His current portfolio covers AIDS costs and financing, immunization policy, and innovative approaches to global health R&D.

Gina Lagomarsino

Gina Lagomarsino is a Principal and Managing Director at R4D, with a focus on health systems and financing. She leads work on the role of the private sector in health systems, and the Transforming Health Systems initiative, in partnership with the Rockefeller Foundation.

Marty Makinen is a Principal and Managing Director at R4D, with a focus on health financing and human resources for health. Marty leads the Ministerial Leadership Initiative, the work with the Global Health Workforce Alliance, the Capacity Project, and the Agence Française de Développement.

Dennis de Tray is a Principal at R4D. His recent and ongoing projects include work with the World Bank on Southern Africa and with the governments of Kazakhstan and Timor-Leste on strategic planning.

Kanika  Bahl is a Principal and Managing Director at R4D. She will be launching efforts in Marked-Based Solutions for development, including in the areas of impact investing and social enterprise growth. She will also continue expanding R4D's capabilities in global health, including efforts centered around increasing human resources for health and improving the efficiency of aid expenditures.

Nicholas Burnett is a Principal and Managing Director at R4D, leading our Education group. Prior to joining our team, he served as Assistant Director-General for Education at the United Nations Educational, Cultural and Scientific Organisation (UNESCO).

Featured Project

Results for Development Institute (R4D), received a grant from the Bill & Melinda Gates Foundation to conduct a study to enhance global knowledge and understanding of the challenges that Lower Middle Income Countries (LMICs) face as they consider the adoption of new vaccines.